Evaluation of children with craniopharyngioma using carbon-11 methionine PET prior to proton therapy | Zendy

B. Laser | Zendy; Thomas E. Merchant | Zendy; Daniel J. Indelicato | Zendy; ChiaHo Hua | Zendy; Barry L. Shulkin | Zendy; Scott E. Snyder | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Evaluation of children with craniopharyngioma using carbon-11 methionine PET prior to proton therapy

Author(s) -

B. Laser,

Thomas E. Merchant,

Daniel J. Indelicato,

ChiaHo Hua,

Barry L. Shulkin,

Scott E. Snyder

Publication year - 2013

Publication title -

neuro-oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 4.005

H-Index - 125

eISSN - 1523-5866

pISSN - 1522-8517

DOI - 10.1093/neuonc/nos321

Subject(s) - craniopharyngioma , medicine , standardized uptake value , nuclear medicine , positron emission tomography , white matter , brain tumor , magnetic resonance imaging , radiology , pathology

Fluorine-18 ((18)F) fluorodeoxyglucose (FDG) positron emission tomography (PET) is limited in its evaluation of brain tumors due to the high basal activity of the cerebral cortex and white matter. Carbon-11 methionine ((11)C MET) has little uptake under normal conditions. We prospectively investigated the uptake of (18)F FDG and (11)C MET PET in patients with craniopharyngioma prior to proton therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research